LEARN MORE
LEARN MORE

THE SCIENCE BEHIND SUISSELLE

Suisselle’s uniqueness and competitive advantage derives from its patented CHAC Technology, which has allowed formulation of the first of its kind, stabilized meso complex on the market.
Developed and applied in our state-of-the-art production center in Switzerland, CHAC Technology helps to ensure the highest efficiency and long-lasting treatment results of our Mesotherapy products.

” My need, when I use Hyaluronic Acid is safety. Efficiency is important but safety first. apriline® is a very good product line, I use them often, every day.”

– Dr. Philippe Kestemont

CHAC TECHNOLOGY

The patented CHAC Technology is able to modify and exploit the natural properties of Hyaluronic Acid and make it an optimal vehicle for transporting the essential nutrients to the skin.
In order to obtain such results, the mixture undergoes simultaneous pressure and shear deformation, which results in molecular complexes. The additives, which are mostly small organic molecules, stabilize the Hyaluronic Acid to increase the bioavailability of the additives and provide long-lasting effects.

Crosslinked Hyaluronic Acid Compositions is an innovative and patented technology* with three phases.

*European Patent Application No. 14788611.3, United States Patent Application No. 20160074519, WO2014/172784A1